Business Context and Reporting Period
Pediatrix Medical Group, Inc. (PMG) filed its Quarterly Report on Form 10-Q for the period ended June 30, 2004. PMG operates as a management company for pediatric and neonatal physician practices, providing services through affiliated professional contractors. During the six months ended June 30, 2004, the Company completed the acquisition of seven physician group practices for approximately $38.7 million.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2004 | Six Months Ended June 30, 2003 |
|---|---|---|
| Net Patient Service Revenue | $300.3 million | $259.9 million |
| Net Income | $46.6 million | $36.9 million |
| Diluted EPS | $1.84 | $1.49 |
| Operating Margin | 24.8% | 23.1% |
| Cash and Cash Equivalents | $19.7 million | $11.6 million (end of period 2003) |
| Working Capital | $50.0 million | $24.5 million (Dec 31, 2003) |
| Total Debt (Current + Long-term) | $1.9 million | $1.9 million (Dec 31, 2003) |
Cash Flow: Net cash provided by operating activities was $33.3 million. Net cash used in investing activities was $41.4 million, primarily due to acquisition payments ($38.7 million). Net cash used in financing activities was negligible ($37,000), driven by stock repurchases ($23.2 million) offset by proceeds from stock issuances ($23.3 million).
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 15.5% year-over-year. Approximately 54% of this increase ($21.8 million) was attributable to acquisitions and new hospital contracts. Same-unit revenue grew 7.2%, driven by a 2.8% increase in neonatal intensive care patient days and modest price increases.
- Expense Increases: Practice salaries and benefits rose 13.4% to $170.4 million, reflecting new staff for acquisitions and volume growth. Practice supplies increased 28.8% due to the inclusion of a metabolic screening laboratory acquired in 2003.
- Profitability: Operating income increased 24.2% to $74.5 million. The operating margin expanded by 1.7 percentage points due to operational efficiencies and a reduction in general and administrative expenses as a percentage of revenue.
- Balance Sheet: Goodwill increased by $36.3 million due to recent acquisitions. Accounts payable and accrued expenses decreased significantly from $112.0 million to $92.0 million, largely due to the payment of accrued salaries and bonuses.
Outlook, Risks, and Contingencies
Capital Resources and Liquidity: In July 2004, the Company secured a new $150 million revolving line of credit maturing in July 2009, replacing its prior facility. The Company had no outstanding borrowings under the line of credit as of August 2, 2004. Management anticipates that operating cash flows and the new credit facility will be sufficient to meet obligations for the next 12 months.
Stock Repurchases: The Company completed a $50 million repurchase program in July 2004. In August 2004, the Board authorized an additional $50 million repurchase program.
Legal and Regulatory Risks:
- FTC Investigation: An ongoing investigation regarding competition issues related to the 2001 acquisition of Magella Healthcare Corporation remains active.
- Government Inquiries: The Company is subject to active federal and state investigations regarding Medicaid and TRICARE billing practices. A search warrant was served in November 2003 on the Las Vegas practice regarding Medicaid billings.
- Malpractice: The Company faces routine medical malpractice claims. While management believes current insurance coverage is adequate, future claims in excess of coverage could have a material adverse effect.
Forward-Looking Statements: The filing contains forward-looking statements regarding future performance, which are subject to risks including changes in reimbursement rates, regulatory actions, and the ability to integrate acquisitions.
Investor Verification Checklist
- Acquisition Integration: Verify the financial performance and integration status of the seven physician groups acquired in the first half of 2004.
- Regulatory Exposure: Monitor the status and potential financial impact of the ongoing FTC, Medicaid, and TRICARE investigations.
- Debt Covenants: Review compliance with the new $150 million credit facility covenants, specifically the minimum net worth requirement and restrictions on dividends.
- Stock-Based Compensation: Note that reported net income does not reflect fair value accounting for stock options; pro forma net income for the six months ended June 30, 2004, would be $41.2 million.
- Reimbursement Trends: Assess the sustainability of the 7.2% same-unit revenue growth amidst potential changes in managed care contracting and reimbursement rates.